Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

For: Servais L, Seferian A, Ben Yahou R, Leturcq F, Zehrouni K, Benali M, Decostre V, Delahais V, Butoianu N, Cuisset J, Cances C, Le Moing A, Laugel V, Klein A, Sabouraud P, Le Guiner C, Moullier P, Moraux A, Hogrel J, Montus M, Voit T. P.20.14 Non ambulant patients with deletion treatable by exon skipping 53 present a more severe phenotype than the general Duchenne population. Neuromuscul Disord 2013. [DOI: 10.1016/j.nmd.2013.06.704] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]

For:	Servais L, Seferian A, Ben Yahou R, Leturcq F, Zehrouni K, Benali M, Decostre V, Delahais V, Butoianu N, Cuisset J, Cances C, Le Moing A, Laugel V, Klein A, Sabouraud P, Le Guiner C, Moullier P, Moraux A, Hogrel J, Montus M, Voit T. P.20.14 Non ambulant patients with deletion treatable by exon skipping 53 present a more severe phenotype than the general Duchenne population. Neuromuscul Disord 2013. [DOI: 10.1016/j.nmd.2013.06.704] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]

Number

Cited by Other Article(s)

Ricotti V, Muntoni F, Voit T. Challenges of clinical trial design for DMD. Neuromuscul Disord 2015;25:932-5. [PMID: 26584589 DOI: 10.1016/j.nmd.2015.10.007] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/30/2015] [Accepted: 10/14/2015] [Indexed: 12/15/2022]